Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Current Oncology Reports|February 10, 2023
Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug ConjugatesQuincy ChuJournal of Chemotherapy (Florence, Italy)|October 15, 2024
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapyDavid Moon, Quincy Chu, Carrie YeJournal of Immunotherapy (Hagerstown, Md. : 1997)|January 9, 2022
Rapid Unmasking of Immune-related Adverse Events After Discontinuation of Chemotherapy in Chemo-immunotherapy RegimensNicholas D Riopel, Quincy Chu, John Walker, et al.Current Oncology (Toronto, Ont.)|June 26, 2024
Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in CanadaQuincy Chu, Kaushik Sripada, Sarah Vaselenak, et al.Pharmacoeconomics|April 23, 2025
Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in CanadaNick Jovanoski, Sarah Vaselenak, Andrew Hogan, et al.BMJ Open Respiratory Research|January 29, 2022
Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitorsLei Zhang, John Coffin, Kim Formenti, et al.World Journal of Clinical Oncology|May 26, 2011
Targeting metastatic upper gastrointestinal adenocarcinomasJennifer L Spratlin, Quincy Chu, Sheryl Koski, et al.Oncotarget|February 15, 2011
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel futureKaren Mulder, Sheryl Koski, Andrew Scarfe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint InhibitionBarbara Melosky, Quincy Chu, Rosalyn Juergens, et al.Lung Cancer (Amsterdam, Netherlands)|September 6, 2005
Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guidelineQuincy Chu, Mark Vincent, Diane Logan, et al.Pageof 6